BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10491523)

  • 1. Multidrug resistance phenotype in high grade soft tissue sarcoma: correlation of P-glycoprotein immunohistochemistry with pathologic response to chemotherapy.
    Jimenez RE; Zalupski MM; Frank JJ; Du W; Ryan JR; Lucas DR
    Cancer; 1999 Sep; 86(6):976-81. PubMed ID: 10491523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma.
    Coley HM; Verrill MW; Gregson SE; Odell DE; Fisher C; Judson IR
    Eur J Cancer; 2000 May; 36(7):881-8. PubMed ID: 10785593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein expression in soft-tissue sarcomas.
    Nakanishi H; Myoui A; Ochi T; Aozasa K
    J Cancer Res Clin Oncol; 1997; 123(6):352-6. PubMed ID: 9222302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of P-glycoprotein, multidrug resistance-associated protein 1, and lung resistance-related protein in human soft tissue sarcomas before and after hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan.
    Komdeur R; Plaat BE; Hoekstra HJ; Molenaar WM; Hollema H; van den Berg E; Mastik MF; van der Graaf WT
    Cancer; 2001 May; 91(10):1940-8. PubMed ID: 11346877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse transcriptase-polymerase chain reaction amplification of MDR1 gene expression in adult soft tissue sarcomas.
    Oda Y; Schneider-Stock R; Ryś J; Gruchała A; Niezabitowski A; Roessner A
    Diagn Mol Pathol; 1996 Jun; 5(2):98-106. PubMed ID: 8727096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS study.
    Martin-Broto J; Gutierrez AM; Ramos RF; Lopez-Guerrero JA; Ferrari S; Stacchiotti S; Picci P; Calabuig S; Collini P; Gambarotti M; Bague S; Dei Tos AP; Palassini E; Luna P; Cruz J; Cubedo R; Martinez-Trufero J; Poveda A; Casali PG; Fernandez-Serra A; Lopez-Pousa A; Gronchi A
    Mol Cancer Ther; 2014 Jan; 13(1):249-59. PubMed ID: 24145283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of P-glycoprotein expression in soft tissue sarcomas of the extremities.
    Serra M; Scotlandi K; Manara MC; Maurici D; Benini S; Sarti M; Nini G; Barbanti-Brodano G; Baldini N
    Cytotechnology; 1996; 19(3):253-6. PubMed ID: 8862015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The correlation of multidrug resistance phenotype with clinical response to chemotherapy in laryngeal cancer].
    Li X; Yang C; Su Z; Song Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Sep; 15(9):401-2, 404. PubMed ID: 12541888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDR1 gene expression: evaluation of its use as a molecular marker for prognosis and chemotherapy of bone and soft tissue sarcomas.
    Stein U; Shoemaker RH; Schlag PM
    Eur J Cancer; 1996 Jan; 32A(1):86-92. PubMed ID: 8695249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDR-1 expression in non-Hodgkin's lymphomas is unrelated to treatment intensity or response to therapy.
    Finnegan MC; Royds J; Goepel JR; Lorigan P; Hancock BW; Goyns MH
    Leuk Lymphoma; 1995 Jul; 18(3-4):297-302. PubMed ID: 8535196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of multidrug resistance-associated proteins in paediatric soft tissue sarcomas before and after chemotherapy.
    Citti A; Boldrini R; Inserra A; Alisi A; Pessolano R; Mastronuzzi A; Zin A; De Sio L; Rosolen A; Locatelli F; Fruci D
    Int J Oncol; 2012 Jul; 41(1):117-24. PubMed ID: 22504834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP-binding cassette superfamily transporter gene expression in human soft tissue sarcomas.
    Oda Y; Saito T; Tateishi N; Ohishi Y; Tamiya S; Yamamoto H; Yokoyama R; Uchiumi T; Iwamoto Y; Kuwano M; Tsuneyoshi M
    Int J Cancer; 2005 May; 114(6):854-62. PubMed ID: 15609299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of P-glycoprotein expression and drug efflux in human soft tissue and bone sarcomas.
    Kunikane H; Zalupski MM; Ramachandran C; KuKuruga MA; Lucas D; Ryan JR; Krishan A
    Cytometry; 1997 Aug; 30(4):197-203. PubMed ID: 9298839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a multidrug resistance gene in human rheumatoid synovium.
    Jorgensen C; Sun R; Rossi JF; Costes J; Richard D; Bologna C; Sany J
    Rheumatol Int; 1995; 15(2):83-6. PubMed ID: 7481486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance P-glycoprotein monoclonal antibody JSB-1 crossreacts with pyruvate carboxylase.
    Rao VV; Anthony DC; Piwnica-Worms D
    J Histochem Cytochem; 1995 Dec; 43(12):1187-92. PubMed ID: 8537634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric assessment of multidrug resistance (MDR) phenotype in acute myeloid leukaemia.
    Hart SM; Ganeshaguru K; Lyttelton MP; Prentice HG; Hoffbrand AV; Mehta AB
    Leuk Lymphoma; 1993 Oct; 11(3-4):239-48. PubMed ID: 7903178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is P-glycoprotein a sufficient marker for multidrug resistance in vivo? Immunohistochemical staining for P-glycoprotein in children and adult leukemia: correlation with clinical outcome.
    Kaczorowski S; Ochocka M; Kaczorowska M; Aleksandrowicz R; Matysiakl M; Karwacki M
    Leuk Lymphoma; 1995 Dec; 20(1-2):143-52. PubMed ID: 8750636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of multidrug resistance (MDR) by transfection of MCF-10A cell line with c-Ha-ras and c-erbB-2 oncogenes.
    Sabbatini AR; Basolo F; Valentini P; Mattii L; Calvo S; Fiore L; Ciardiello F; Petrini M
    Int J Cancer; 1994 Oct; 59(2):208-11. PubMed ID: 7927921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of P-glycoprotein, a multidrug-resistance gene product, is induced by radiotherapy in patients with oral squamous cell carcinoma.
    Ng IO; Lam KY; Ng M; Kwong DL; Sham JS
    Cancer; 1998 Sep; 83(5):851-7. PubMed ID: 9731886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.
    Izquierdo MA; van der Zee AG; Vermorken JB; van der Valk P; Beliën JA; Giaccone G; Scheffer GL; Flens MJ; Pinedo HM; Kenemans P
    J Natl Cancer Inst; 1995 Aug; 87(16):1230-7. PubMed ID: 7563169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.